Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

China TCM Ltd. Pays $1.3 Billion for 81% Stake in Tianjiang Pharma

publication date: Jan 29, 2015
China Traditional Chinese Medicine Co. Ltd. will pay as much as $1.3 billion for an 81.5% stake in Jiangyin Tianjiang Pharmaceutical Co., a rival TCM company. Once combined, the two companies will claim a greater than 50% share in China's concentrated TCM granules market. China TCM, formerly known as Winteam Pharma, is a part of the sprawling state-owned China National Pharmaceutical Group Corporation (Sinopharm), which continues to hold a 40% stake in China TCM. More details....

Stock Symbol: (HK: 570)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital